We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Elpis BioMed Closes Funding Round to Commercialise Novel Technology Platform for Generating Human Cell Types

News   Nov 21, 2017

 
Elpis BioMed Closes Funding Round to Commercialise Novel Technology Platform for Generating Human Cell Types

Human neurons stained for MAP2 and synaptophysin

 
 
 

RELATED ARTICLES

Hunt for the Missing T-Cells in Glioblastoma Patients

News

Glioblastoma brain tumors can have an unusual effect on the body’s immune system, often causing a dramatic drop in the number of circulating T-cells that help drive the body’s defenses.

READ MORE

Medicine of the Future Against Infection and Inflammation?

News

Researchers have mapped how the body's own peptides act to reduce infection and inflammation by deactivating the toxic substances formed in the process.

READ MORE

Targeting a Brain Mechanism Could Treat Aggression

News

Neuroscientists have identified a brain mechanism that is linked to aggression and violent behavior, potentially forming the basis for treating aggression in several psychiatric disorders.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE